(MENAFN- ProactiveInvestors)Life sciences group TyraTech (LON:TYR) announced today that its head lice treatment Vamousse is set to be found in major US retailer Rite Aid Corporation after striking a new distribution agreement. With the addition of this Fortune 500 firm Vamousse is now available in all of the top four retail pharmacy chains in the US and nationwide can be found in more than 24000 individual stores including Walmart Walgreens and CVS Health. Chief executive Bruno Jactel said: "We recognize that the purchase of head lice treatment is for almost all parents and caregivers is an emergency buy. "When a child is identified with a lice infestation you want to find a resolution immediately. For this reason achieving strong and comprehensive distribution in our major target markets is paramount. 'Our strategy has been to make sure that the consumer can find our product in whatever store is closest to home and then to drive brand awareness through our marketing programs. Broad distribution helps us achieve the best return on investment for our marketing spend.' TyraTech has also made progress in increasing Vamousse's UK presence having increased its store presence in Tesco and Sainsbury's to achieve coverage of more than 7800 retail stores. "We continue to build on the success of establishing the Vamousse head lice franchise and monetizing our technology. These additional distribution agreements across major retailers in both the US and UK are strong validation for the value and efficacy of our products for consumers and retailers alike" said Jactel. Vamousse is now widely on sale throughout the UK and US - and is the fastest growing national brand head lice product in the US..
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.